Aref A - Search Results

1

Radiobiological characterization of two human chemotherapy-resistant intermediate grade non-Hodgkin's lymphoma cell lines.

Aref A, Mohammad R, Yudelev M, Choudhuri R, Strowbridge A, Orton C, al-Katib A. Aref A, et al. Radiat Oncol Investig. 1999;7(3):158-62. doi: 10.1002/(SICI)1520-6823(1999)7:3<158::AID-ROI4>3.0.CO;2-B. Radiat Oncol Investig. 1999. PMID: 10406057

2

Value of radiation therapy in the management of chemoresistant intermediate grade non-Hodgkin's lymphoma.

Aref A, Narayan S, Tekyi-Mensah S, Varterasian M, Dan M, Eilender D, Karanes C, al-Katib A. Aref A, et al. Radiat Oncol Investig. 1999;7(3):186-91. doi: 10.1002/(SICI)1520-6823(1999)7:3<186::AID-ROI8>3.0.CO;2-2. Radiat Oncol Investig. 1999. PMID: 10406061

3

Neutron and photon clonogenic survival curves of two chemotherapy resistant human intermediate-grade non-Hodgkin lymphoma cell lines.

Aref A, Yudelev M, Mohammad R, Choudhuri R, Orton C, Al-Katib A. Aref A, et al. Int J Radiat Oncol Biol Phys. 1999 Nov 1;45(4):999-1003. doi: 10.1016/s0360-3016(99)00258-8. Int J Radiat Oncol Biol Phys. 1999. PMID: 10571208

4

Design considerations for a computer controlled multileaf collimator for the Harper Hospital fast neutron therapy facility.

Maughan RL, Yudelev M, Aref A, Chuba PJ, Forman J, Blosser EJ, Horste T. Maughan RL, et al. Among authors: aref a. Med Phys. 2002 Apr;29(4):499-508. doi: 10.1118/1.1463061. Med Phys. 2002. PMID: 11991121

5

A global strategy for radiotherapy: a WHO consultation.

Porter A, Aref A, Chodounsky Z, Elzawawy A, Manatrakul N, Ngoma T, Orton C, Van't Hooft E, Sikora K. Porter A, et al. Among authors: aref a. Clin Oncol (R Coll Radiol). 1999;11(6):368-70. doi: 10.1053/clon.1999.9086. Clin Oncol (R Coll Radiol). 1999. PMID: 10663325 Review. No abstract available.

6

The influence of beam energy on the outcome of postoperative radiotherapy in head and neck cancer patients: secondary analysis of RTOG 85-03.

Aref A, Berkey BA, Schwade JG, Ensley J, Schuller DE, Haselow RE, Ervin TJ, Laramore GE. Aref A, et al. Int J Radiat Oncol Biol Phys. 2000 May 1;47(2):389-94. doi: 10.1016/s0360-3016(00)00457-0. Int J Radiat Oncol Biol Phys. 2000. PMID: 10802364 Clinical Trial.

7

A blood stem cell transplant in a person with concomitant Hodgkin disease and testicular carcinoma.

Varterasian ML, Aref A, Karanes C. Varterasian ML, et al. Among authors: aref a. Bone Marrow Transplant. 1997 Apr;19(8):857-8. doi: 10.1038/sj.bmt.1700741. Bone Marrow Transplant. 1997. PMID: 9134184

8

Objective evaluation of the quality of voice following radiation therapy for T1 glottic cancer.

Aref A, Dworkin J, Devi S, Denton L, Fontanesi J. Aref A, et al. Radiother Oncol. 1997 Nov;45(2):149-53. doi: 10.1016/s0167-8140(97)00154-0. Radiother Oncol. 1997. PMID: 9424005

9

Sarcoma as a second malignancy after treatment for breast cancer.

Yap J, Chuba PJ, Thomas R, Aref A, Lucas D, Severson RK, Hamre M. Yap J, et al. Among authors: aref a. Int J Radiat Oncol Biol Phys. 2002 Apr 1;52(5):1231-7. doi: 10.1016/s0360-3016(01)02799-7. Int J Radiat Oncol Biol Phys. 2002. PMID: 11955733

10

Larynx motion associated with swallowing during radiation therapy.

Hamlet S, Ezzell G, Aref A. Hamlet S, et al. Among authors: aref a. Int J Radiat Oncol Biol Phys. 1994 Jan 15;28(2):467-70. doi: 10.1016/0360-3016(94)90073-6. Int J Radiat Oncol Biol Phys. 1994. PMID: 8276663

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

326 results

Search Page

Filters